Oculis Holding AG (OCS)
OCS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.62
-3.30% on the day
Market cap
$469.3M
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | OCS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Switzerland |
| IPO year | Not reported by the screener |
| SEC CIK | 0001953530 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | V8 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2025-12-05 |
| Latest annual report | 20-F | 2026-03-04 |
| Latest quarterly / interim | 6-K | 2026-09-30 |
Source: SEC EDGAR submissions feed, 136 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -15.8% |
| 1 month | -28.9% |
| 3 months | -43.2% |
| Year to date | -64.1% |
| 1 year | -65.9% |
| From 52-week high | -78.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| OCSAW | Oculis Holding AG Warrants | $2.23 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ALT | Altimmune Inc. | $2.43 | -5.08% | $472.7M |
| EVO | Evotec SE | $1.34 | -1.82% | $478.5M |
| CBIO | Crescent Biopharma Inc. | $12.91 | -10.72% | $479.5M |
| MNPR | Monopar Therapeutics Inc. | $72.08 | -6.45% | $483.8M |
| BLSM | BlossomHill Therapeutics Inc. | $15.48 | -10.37% | $492.0M |
| ARVN | Arvinas Inc. | $6.84 | -8.19% | $447.2M |
| RZLT | Rezolute Inc. Common Stock (NV) | $4.61 | -5.34% | $445.9M |
| EOLS | Evolus Inc. | $7.51 | -3.10% | $496.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier